Developer docs
API playgroundTry for free, no card

Search company profiles

Pycnogenol

Full company profile

uuid000us8u

Namestring
Pycnogenol
Legal namestring
Horphag Research
Websiteurl
pycnogenol.com
Company typeenum
Private
Founded yearint
1925
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersCointrin, Switzerland
HQ citystring
Cointrin
HQ countrystring
Switzerland
HQ regionstring
Europe
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pine bark extract, nutraceutical ingredients, botanical raw materials, dietary supplement ingredients, natural antioxidant extracts
Industry1 code
PRIMARYCRADAGAD
Herbal & Botanical Supplements
SIC code1 code
  • Medicinal Chemicals & Botanical Products2833
Product category
Nutraceutical Ingredients
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Raw Material Sales (B2B)
TypeLicensing Royalties
Description

Horphag Research supplies Pycnogenol® as a raw material to companies that produce dietary supplements, multi-vitamins, cosmetics and health products worldwide. The company generates revenue by selling the patented ingredient to finished product manufacturers.

pycnogenol.com
Marketing channels9 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Operations, Marketing or Sales, Personnel, Supply Chain
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Pycnogenol® is a patented natural plant extract derived from the bark of French maritime pine (Pinus pinaster), containing procyanidins, bioflavonoids, and phenolic acids. Horphag Research produces and supplies it as a B2B raw material to dietary supplement, multi-vitamin, cosmetic, and health product manufacturers worldwide, with the ingredient available in more than 1,000 finished products across 80+ countries.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • 29% reduction in lipedema symptoms, 8% decrease in body fat in women over 60 days (100 women clinical study, Cureus Journal)
+6 more records
Product overview1 text field

Pycnogenol® is a premium, evidence-based natural ingredient supplied as a raw material by Horphag Research to companies that manufacture dietary supplements, cosmetics, and health products. The product is a French maritime pine bark extract containing procyanidins, bioflavonoids, and phenolic acids. Available in more than 1000 finished products worldwide, it is supported by over 40 years of research including 160+ clinical trials and 450+ scientific publications. Horphag Research offers partners a Clinical Dosage Calculator tool for formulation guidance and publishes a quarterly Pycnogenol® Report Newsletter to disseminate new clinical findings.

Product and service1 record
1Pycnogenol® French Maritime Pine Bark Extract
CategoryNutraceutical Ingredients
Description

Natural plant extract from the bark of French maritime pine (Pinus pinaster) grown along the coast of southwest France. Contains a unique combination of procyanidins, bioflavonoids, and phenolic acids and is sold as a raw ingredient to companies that manufacture dietary supplements, multi-vitamins, cosmetics, and health products.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership10 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

DKSH serves as regional distributor for Pycnogenol® in China (DKSH Performance Materials China), Italy, Japan (DKSH Japan), Malaysia, Philippines, Taiwan, Thailand, Vietnam, and India. Responsible for raw material distribution and sales support in these markets.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Regional agent responsible for Pycnogenol® distribution in Australia. Contact: Mr. Wayne Coote, Level 2, Building B, 14 Rodborough Road, French Forest, NSW 2086, Australia.

3Tradepia Corporation (Japan)
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Regional agent for Pycnogenol® distribution in Japan. Contact: Mr. Masafumi Matsushita, Tokyo St. Building, 4-9-4 Chome, Hatchobori, Chuo-ku, Tokyo.

pycnogenol.com
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Regional agent for Pycnogenol® distribution in South Korea. Contact: Mr. Kim B.D., 3rd Floor, Zeus Building, 3-16, Yangjae-dong, Seocho-ku, Seoul.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Regional agent for Pycnogenol® distribution in Malaysia. Contact: Mr. Loke Ken Nee, No 28-2 Jalan Damar SD 15/1, Bandar Sri Damansara, Kuala Lumpur.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Regional agent for Pycnogenol® distribution in Taiwan. Contact: 6F-2, No.910, Sec.2, Taiwan Blvd., Xitun Dist., Taichung City.

7BioWell Nutriscience Corporation (Taiwan)
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Regional agent for Pycnogenol® distribution in Taiwan. Contact: 8F-3, No.200 Sec. 4, Wenxin Road, North Dist., Taichung City.

pycnogenol.com
8BONANZANEUTRA CO., LTD. (Thailand)
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Regional agent for Pycnogenol® distribution in Thailand. Contact: Ms. Sinitnuch Leepatanapan, CMO, 589/75 Central City Tower, 14th Floor, Bangkok.

pycnogenol.com
9Horphag Research (USA) Inc.
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

North American raw material supplier for Pycnogenol®. Located at 5 Marine View Plaza, Suite 403, Hoboken, NJ 07030-5722, USA. Tel: +1 201-459-0300.

pycnogenol.com
10Cebu Hope Center
Strategic tierMinorTypeOthers
Description

Horphag Research supports the Cebu Hope Center founded by Dona Maria M de Aboitiz in 1981, which protects, cares for and rebuilds the lives of underprivileged children in the Philippines. The company covers the center's annual needs and organizes local doctors to donate their time and services.

pycnogenol.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

U.S.-based supplier of patented, science-backed botanical extracts and nutraceutical ingredients (e.g., Curcumin C3 Complex, BioPerine, ForsLean) sold to dietary supplement and cosmetic manufacturers — closest functional analog to Horphag's branded botanical extract business model.

TypeBroad incumbent
Description

Privately-held specialty ingredient manufacturer serving human/animal nutrition and cosmetics with proprietary botanical extracts and antioxidant systems; competes with Horphag in the branded polyphenol/antioxidant ingredient space.

TypeDirect peer
Description

Italian supplier of proprietary, clinically documented botanical extracts (e.g., Meriva curcumin, Enovita grape seed, Relissa rosemary) sold B2B to supplement and cosmetic brands globally — directly analogous to Horphag's Pycnogenol model of branded, patented plant extract ingredients.

TypeDirect peer
Description

French supplier of botanical extracts for nutrition, health and cosmetics (e.g., OliOla olive, Tinofend, Cognivia) with a comparable B2B ingredient model and similar focus on plant-derived polyphenol actives relevant to supplement and skincare customers.

TypeBroad incumbent
Description

Global nutrition, health and beauty ingredients major offering vitamins, polyphenols and botanical extracts that compete with Pycnogenol for formulation slots in supplements, functional foods and cosmeceuticals.

6Naturex (Givaudan)
TypeBroad incumbent
Description

Naturex was a leading botanical extract supplier to nutrition and cosmetics before its acquisition by Givaudan; within Givaudan's Active Beauty and Taste & Wellbeing segments it competes broadly with Horphag's ingredient proposition at much greater scale.

TypeBroad incumbent
Description

Frutarom was a direct peer in botanical and nutraceutical ingredients before its 2018 acquisition by IFF; today the combined IFF Health & Biosciences platform offers a much broader ingredient portfolio that overlaps with Horphag's B2B botanical extract offering.

TypeBroad incumbent
Description

Global agribusiness with a sizable Health & Wellness ingredient platform including plant-based extracts and nutraceuticals sold to supplement and food manufacturers; overlaps with Horphag's B2B customer base at far greater scale.

TypeBroad incumbent
Description

Major agribusiness with a growing health ingredients portfolio including botanical extracts and polyphenol-based ingredients for supplement and functional food customers — broad incumbent competing for similar B2B formulation slots.

TypeDirect peer
Description

Spain-based manufacturer of standardized botanical extracts (e.g., ABAlife, Pomanox, Mediteanox) sold as branded B2B ingredients for dietary supplements and functional cosmetics — similar premium extract positioning and clinical evidence emphasis as Horphag Research.

Market position
Strengths2 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks3 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Pycnogenol

Nutraceutical Ingredientspycnogenol.com

Pycnogenol firmographics

Firmographics
Name
Pycnogenol
Legal name
Horphag Research
Website
https://pycnogenol.com
Company type
Private
Founded year
1925
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

Pycnogenol industry classification

Industry
Product category
Nutraceutical Ingredients
SIC
Medicinal Chemicals & Botanical Products (2833)
akta.pro industry
PRIMARYCRADAGAD
Herbal & Botanical Supplements

Keywords

  • Pine bark extract
  • Nutraceutical ingredients
  • Botanical raw materials
  • Dietary supplement ingredients
  • Natural antioxidant extracts

Where Pycnogenol is headquartered

Location

Headquarters

HQ city
Cointrin
HQ country
Switzerland
HQ region
Europe

Offices3 records

Markets served

Pycnogenol business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Operations, Marketing or Sales, Personnel, Supply Chain

Revenue model

  1. Raw Material Sales (B2B): Horphag Research supplies Pycnogenol® as a raw material to companies that produce dietary supplements, multi-vitamins, cosmetics and health products worldwide. The company generates revenue by selling the patented ingredient to finished product manufacturers.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels9 records

Pycnogenol product offering

Product offering

Core offering

Pycnogenol® is a patented natural plant extract derived from the bark of French maritime pine (Pinus pinaster), containing procyanidins, bioflavonoids, and phenolic acids. Horphag Research produces and supplies it as a B2B raw material to dietary supplement, multi-vitamin, cosmetic, and health product manufacturers worldwide, with the ingredient available in more than 1,000 finished products across 80+ countries.

Product overview

Pycnogenol® is a premium, evidence-based natural ingredient supplied as a raw material by Horphag Research to companies that manufacture dietary supplements, cosmetics, and health products. The product is a French maritime pine bark extract containing procyanidins, bioflavonoids, and phenolic acids. Available in more than 1000 finished products worldwide, it is supported by over 40 years of research including 160+ clinical trials and 450+ scientific publications. Horphag Research offers partners a Clinical Dosage Calculator tool for formulation guidance and publishes a quarterly Pycnogenol® Report Newsletter to disseminate new clinical findings.

Differentiator

Problem solved

Functional benefit

Products and services

  • Pycnogenol® French Maritime Pine Bark Extract Natural plant extract from the bark of French maritime pine (Pinus pinaster) grown along the coast of southwest France. Contains a unique combination of procyanidins, bioflavonoids, and phenolic acids and is sold as a raw ingredient to companies that manufacture dietary supplements, multi-vitamins, cosmetics, and health products.

Quantifiable outcome

  • 29% reduction in lipedema symptoms, 8% decrease in body fat in women over 60 days (100 women clinical study, Cureus Journal)
  • +6 more outcomes

Companies that use Pycnogenol

Customer profile

Segments2 records

Ideal customer profiles1 record

Pycnogenol technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Pycnogenol partnerships and signals

Strategic signal

Partnerships

Ten partnerships are on record, tiered core and minor.

  • DKSH (Various Regions)coreChannel Partner/ Reseller/ DistributorDKSH serves as regional distributor for Pycnogenol® in China (DKSH Performance Materials China), Italy, Japan (DKSH Japan), Malaysia, Philippines, Taiwan, Thailand, Vietnam, and India. Responsible for raw material distribution and sales support in these markets.
  • Pathway International (Australia)coreChannel Partner/ Reseller/ DistributorRegional agent responsible for Pycnogenol® distribution in Australia. Contact: Mr. Wayne Coote, Level 2, Building B, 14 Rodborough Road, French Forest, NSW 2086, Australia.
  • Tradepia Corporation (Japan)coreChannel Partner/ Reseller/ DistributorRegional agent for Pycnogenol® distribution in Japan. Contact: Mr. Masafumi Matsushita, Tokyo St. Building, 4-9-4 Chome, Hatchobori, Chuo-ku, Tokyo.
  • Jupiter International (Korea)coreChannel Partner/ Reseller/ DistributorRegional agent for Pycnogenol® distribution in South Korea. Contact: Mr. Kim B.D., 3rd Floor, Zeus Building, 3-16, Yangjae-dong, Seocho-ku, Seoul.
  • Membrahealth Marketing (Malaysia)minorChannel Partner/ Reseller/ DistributorRegional agent for Pycnogenol® distribution in Malaysia. Contact: Mr. Loke Ken Nee, No 28-2 Jalan Damar SD 15/1, Bandar Sri Damansara, Kuala Lumpur.
  • Bioinventor International (Taiwan)minorChannel Partner/ Reseller/ DistributorRegional agent for Pycnogenol® distribution in Taiwan. Contact: 6F-2, No.910, Sec.2, Taiwan Blvd., Xitun Dist., Taichung City.
  • BioWell Nutriscience Corporation (Taiwan)minorChannel Partner/ Reseller/ DistributorRegional agent for Pycnogenol® distribution in Taiwan. Contact: 8F-3, No.200 Sec. 4, Wenxin Road, North Dist., Taichung City.
  • BONANZANEUTRA CO., LTD. (Thailand)minorChannel Partner/ Reseller/ DistributorRegional agent for Pycnogenol® distribution in Thailand. Contact: Ms. Sinitnuch Leepatanapan, CMO, 589/75 Central City Tower, 14th Floor, Bangkok.
  • Horphag Research (USA) Inc.coreChannel Partner/ Reseller/ DistributorNorth American raw material supplier for Pycnogenol®. Located at 5 Marine View Plaza, Suite 403, Hoboken, NJ 07030-5722, USA. Tel: +1 201-459-0300.
  • Cebu Hope CenterminorOthersHorphag Research supports the Cebu Hope Center founded by Dona Maria M de Aboitiz in 1981, which protects, cares for and rebuilds the lives of underprivileged children in the Philippines. The company covers the center's annual needs and organizes local doctors to donate their time and services.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Pycnogenol competitors and assessment

Company assessment

Direct peers

  • Sabinsa: U.S.-based supplier of patented, science-backed botanical extracts and nutraceutical ingredients (e.g., Curcumin C3 Complex, BioPerine, ForsLean) sold to dietary supplement and cosmetic manufacturers — closest functional analog to Horphag's branded botanical extract business model.
  • Indena: Italian supplier of proprietary, clinically documented botanical extracts (e.g., Meriva curcumin, Enovita grape seed, Relissa rosemary) sold B2B to supplement and cosmetic brands globally — directly analogous to Horphag's Pycnogenol model of branded, patented plant extract ingredients.
  • Nexira: French supplier of botanical extracts for nutrition, health and cosmetics (e.g., OliOla olive, Tinofend, Cognivia) with a comparable B2B ingredient model and similar focus on plant-derived polyphenol actives relevant to supplement and skincare customers.
  • Euromed: Spain-based manufacturer of standardized botanical extracts (e.g., ABAlife, Pomanox, Mediteanox) sold as branded B2B ingredients for dietary supplements and functional cosmetics — similar premium extract positioning and clinical evidence emphasis as Horphag Research.

Broad incumbents

  • Kemin Industries: Privately-held specialty ingredient manufacturer serving human/animal nutrition and cosmetics with proprietary botanical extracts and antioxidant systems; competes with Horphag in the branded polyphenol/antioxidant ingredient space.
  • dsm-firmenich: Global nutrition, health and beauty ingredients major offering vitamins, polyphenols and botanical extracts that compete with Pycnogenol for formulation slots in supplements, functional foods and cosmeceuticals.
  • Naturex (Givaudan): Naturex was a leading botanical extract supplier to nutrition and cosmetics before its acquisition by Givaudan; within Givaudan's Active Beauty and Taste & Wellbeing segments it competes broadly with Horphag's ingredient proposition at much greater scale.
  • Frutarom (IFF Health & Biosciences): Frutarom was a direct peer in botanical and nutraceutical ingredients before its 2018 acquisition by IFF; today the combined IFF Health & Biosciences platform offers a much broader ingredient portfolio that overlaps with Horphag's B2B botanical extract offering.
  • ADM Health & Wellness: Global agribusiness with a sizable Health & Wellness ingredient platform including plant-based extracts and nutraceuticals sold to supplement and food manufacturers; overlaps with Horphag's B2B customer base at far greater scale.
  • Cargill Health Technologies: Major agribusiness with a growing health ingredients portfolio including botanical extracts and polyphenol-based ingredients for supplement and functional food customers — broad incumbent competing for similar B2B formulation slots.

Market position

Strengths2 records

Weaknesses5 records

Competitive moat4 records

Key risks3 records

Key highlights6 records

Customer concentration

Pycnogenol social profiles

Digital presence

Pycnogenol financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Pycnogenol leadership team

Management profile

Number of profiles

Profiles1 record

Pycnogenol funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Pycnogenol M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pycnogenol

What does Pycnogenol do?

Pycnogenol® is a patented natural plant extract derived from the bark of French maritime pine (Pinus pinaster), containing procyanidins, bioflavonoids, and phenolic acids. Horphag Research produces and supplies it as a B2B raw material to dietary supplement, multi-vitamin, cosmetic, and health product manufacturers worldwide, with the ingredient available in more than 1,000 finished products across 80+ countries.

Is Pycnogenol a public or private company?

Pycnogenol is a private company. It is classified as unknown and is currently operating.

When was Pycnogenol founded?

Pycnogenol was founded in 1925. It employs 11 to 50 people.

Where is Pycnogenol based?

Pycnogenol is headquartered in Cointrin, Switzerland, in the Europe region.

How does Pycnogenol make money?

One revenue line is on record: raw Material Sales (B2B).

Who are Pycnogenol's main competitors?

Direct peers on record are Sabinsa, Indena, Nexira and Euromed. Broad incumbents are Kemin Industries, dsm-firmenich, Naturex (Givaudan), Frutarom (IFF Health & Biosciences), ADM Health & Wellness and Cargill Health Technologies.

Does Pycnogenol have an API?

No public API is recorded for Pycnogenol.

What industry is Pycnogenol in?

Pycnogenol's product category is Nutraceutical Ingredients. Its primary akta.pro industry code is CRADAGAD, Herbal & Botanical Supplements. Its SIC code is 2833.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Business & FinancialNew Study Finds Pycnogenol® Improves Quality Of Life And Symptoms Associated With Osteopenia And Osteoporosis In Post-Menopausal WomenA randomized, double-blind, placebo-controlled trial of 67 post-menopausal women with osteopenia or osteoporosis found that Pycnogenol® improved vitality by 14% and physical comfort by 24.7% after three months. The supplement also reduced the bone-resorption marker CTX-1 by about 10.6% and was safe through six months.Cosmetics BusinessStudy shows that Horphag Research's Pycnogenol retains skin moisture and elasticityA peer-reviewed study of 76 participants found daily 100mg Pycnogenol supplementation improved skin elasticity, firmness, and lightening. The study also showed reduced transepidermal water loss, indicating better skin barrier function. Researchers concluded regular intake benefits skin in urban environments.PR NewswireStudy: Pycnogenol® Shown to Improve Hair Density in Menopausal WomenA double-blind, placebo-controlled study of 63 menopausal women found that taking 150mg of Pycnogenol daily increased hair density by 30% after two months and 23% after six months. The supplement also reduced scalp transepidermal water loss and improved scalp microcirculation. Horphag Research plans further clinical trials.nutraingredients-asia.com‘Double approach’: Skin care brands launching oral supplements for anti-hyperpigmentation as awareness growsHorphag Research reports that skincare brands are increasingly launching oral supplements for anti-hyperpigmentation, with over 1,000 finished products containing Pycnogenol. The ingredient works via antioxidant, anti-inflammatory, and tyrosinase-suppressing mechanisms, and a 12-week trial showed improved skin elasticity and reduced water loss.PR NewswireStudy Shows How Pycnogenol® Works for Managing Symptoms Related to OsteoarthritisA study published in the MDPI Journal of Nutrients found that Pycnogenol polyphenols distribute into synovial fluid in patients with osteoarthritis. The double-blind trial of 33 participants taking 200mg daily for three weeks showed taxifolin and ferulic acid in the treated group but not in controls. The results support previous clinical efficacy studies.